
zzso necrosis factor zzso therapy zzso many Crohn's disease zzso zzso zzso clinically but the rate, extent, and durability of deep tissue healing and factors influencing long-term outcome are zzso 

zzso patients with zzso zzso zzso zzso zzso zzso treated with zzso or zzso were monitored zzso both clinically and zzso using magnetic resonance imaging zzso 

zzso consecutive patients with zzso zzso zzso were treated with zzso zzso zzso zzso or zzso zzso zzso 9; following zzso zzso in combination with a zzso (unless zzso zzso percent of all patients, zzso zzso and zzso of zzso and zzso patients, respectively, demonstrated zzso or response at 3 zzso zzso percent of zzso treated patients maintained clinical zzso at 3 zzso zzso healing lagged behind clinical zzso by a median of 12 zzso The likelihood of clinical zzso at any time was five times greater in patients who had early clinical response within 6 weeks than those zzso A higher number of zzso tracts was associated with reduced clinical zzso All patients who achieved zzso healing maintained healing on zzso treatment, while only zzso maintained healing after zzso of zzso zzso 

Combination zzso and zzso therapy provides sustained benefit in patients with zzso CD zzso Early clinical response is associated with subsequent clinical zzso zzso healing is slower than clinical zzso zzso healed zzso tracts maintain healing on zzso but can recur after zzso of zzso 

